7. Tropendermatologischer Kurs der Deutschen Dermatologischen Gesellschaft (DDG) und der Internationalen Gesellschaft für Dermatologie in den Tropen (ISDT) in Manaus/Brasilien im Oktober 2019

Vanegas A, Effendy I, Schöfer H. 7. Tropendermatologischer Kurs der Deutschen Dermatologischen Gesellschaft (DDG) und der Internationalen Gesellschaft für Dermatologie in den Tropen (ISDT) in Manaus/Brasilien im Oktober 2019. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2020;18(5):529-530.Tagungsberich

Erythema of Rosacea Impairs Health-Related Quality of Life: Results of a Meta-analysis

<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>. </b><a href="https://link.springer.com/article/10.1007/s13555-016-0106-9">https://link.springer.com/article/10.1007/s13555-016-0106-9</a></p> <p><br></p> <p><b>Provide enhanced content for this article</b></p> <p><br></p> <p>If you are an author of this publication and would like to provide additional enhanced content for your article then please contact <a href="http://www.medengine.com/Redeem/”mailto:[email protected]”"><b>[email protected]</b></a>.</p> <p><br></p> <p>The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content.</p> <p><br></p> <p>Other enhanced features include, but are not limited to:</p> <p><br></p> <p>• Slide decks</p> <p>• Videos and animations</p> <p>• Audio abstracts</p> <p>• Audio slides</p

Sinecatechins and imiquimod as proactive sequential therapy of external genital and perianal warts in adults

This review about the proactive sequential therapy (PST) of external genital and perianal warts (EGW) is based on the most current available clinical literature and on the broad clinical experience of a group of international experts, physicians who are well versed in the treatment of human papillomavirus-associated diseases. It provides a practical guide for the treatment of EGW, including epidemiology, etiology, clinical appearance, and diagnostic procedures for these viral infections. Furthermore, the treatment goals and current treatment options, elucidating provider- and patient-applied therapies, and the parameters driving treatment decisions are summarized. Specifically, the mode of action of the topical treatments sinecatechins and imiquimod, as well as the PST for EGW to achieve rapid and sustained clearance is discussed. The group of experts has developed a treatment algorithm giving healthcare providers a practical tool for the treatment of EGW which is very valuable in the presence of many different treatment options

Diagnosis and treatment of Staphylococcus aureus-induced infections of the skin and mucous membranes: S2k and IDA guidelines

Schöfer H, Bruns R, Effendy I, et al. Diagnosis and treatment of Staphylococcus aureus-induced infections of the skin and mucous membranes: S2k and IDA guidelines. Chemotherapie-Journal (CTJ). 2011;20(5):141-156

Diagnosis and treatment of Staphylococcus aureus infections of the skin and mucous membranes

Schöfer H, Bruns R, Effendy I, et al. Diagnosis and treatment of Staphylococcus aureus infections of the skin and mucous membranes. Journal der Deutschen Dermatologischen Gesellschaft. 2011;9(11):953-967

S2k guideline: Rosacea

This updated and upgraded S2k guideline deals with the diagnosis and treatment of rosacea, which is a common, chronic inflammatory skin disease mostly affecting the face. Initially, rosacea is characterized by recurrent erythema, telangiectasia and flushing. Later, the inflammatory component predominates, with persistent erythema with follicular papules, papulopustules and pustules. The development of phyma, which usually occurs on the acral localizations, is the most severe manifestation. For the treatment of rosacea, the interdisciplinary guideline committee, with representatives of the German Dermatological Society (DDG), the Professional Association of German Dermatologists (BVDD), the German Opthalmological Society (DOG), the Society for Dermopharmacy (GD), the Swiss Society for Dermatology and Venereology (SGDV) and the German Rosacea Aid e. V., recommends the avoidance of trigger factors and topical applications of metronidazole, azelaic acid or ivermectin. For symptomatic treatment of persistent centrofacial erythema, the topical vasoconstrictors brimonidine or oxymetazoline can also be used. Systemic therapy is recommended for therapy-resistant and severe forms of rosacea papulopustulosa. The drug of choice is low-dose doxycycline. Alternatively, low-dose isotretinoin can be recommended. Ocular rosacea should be treated with lid margin hygiene. For topical treatment, ciclosporin eye drops, azithromycin, ivermectin or metronidazole are suggested